Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. - Wikidata - awgldk - TriplyDB

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

http://www.wikidata.org/entity/Q36887654

about

ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts Clinical identification of oncogenic drivers and copy number alterations in pituitary tumors.Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology.Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma.MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma.Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance.Ethical considerations of neuro-oncology trial design in the era of precision medicine.Recent advances in molecular pathology of craniopharyngioma.Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy.Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology.What's new in pituitary pathology?High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.Adamantinomatous craniopharyngioma and xanthomatous lesions of the sella.Hypothalamic involvement in craniopharyngioma-Implications for surgical, radiooncological, and molecularly targeted treatment strategies.Dabrafenib and trametinib in BRAFV600E mutated glioma.BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors.Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor.Rathke's Cleft Cyst as Origin of a Pediatric Papillary Craniopharyngioma.

P2860

Q26777288-D1F510F8-D7A1-457B-9289-5FB58C84667C Q36629324-621CF994-C66F-4AFF-AC2C-B108338A2732 Q36785144-D8F8F045-D990-4612-AE04-A12272F8619F Q37105120-E03C0EF7-CB95-43C9-AF95-FAAE4F706C1A Q38685960-AB38DFC9-61D3-452F-8112-6B5D63BACB34 Q38729611-4B73E2FB-3D73-42E0-96B1-CB0F2C0E8285 Q38776792-77340C3F-A9B3-4BB8-AF3C-4D6E957BA5D0 Q38784816-C40F003B-AC83-4457-A3DB-5938C08C0096 Q38801159-BE68E6F1-B187-4C04-8130-7C84911F1F71 Q39337327-A0B61F64-7020-46E4-BC19-88B614A54AF6 Q41150936-98766A88-877F-435F-B214-1DFC72B23229 Q42248290-03C21C8A-F890-4391-A194-B51FECB2792C Q42374906-564EFE7E-A23E-42EF-8587-958EBEB46735 Q47319640-10AD3FCB-3553-4884-ADA4-F8EC98895E60 Q47373550-2935BF49-67C7-4CA8-9D01-4A9A9BBB2A88 Q48011531-F8754363-BCBC-46C3-9766-C375D28F214F Q48120172-AA1FABF0-3EC6-4073-86A2-DCDC1A7E5090 Q48175965-8B72D2B3-B22F-4C44-B2E2-9E9043F97B1C Q48194710-24344D5F-C344-42D4-BD27-3219ACD26008 Q48331876-21CCC9A1-0D22-418B-9383-7C3E149BF23E Q49565156-843F30A4-ECB3-44F6-B8D8-0EF989D4B23F Q52098049-A804C825-BDE0-4F75-8C24-E5649979D957 Q55003763-35C20ABA-A871-4A3F-BF3E-434A5A8CC9A3 Q55349689-0E97EEF4-7B0F-4E10-AC05-5FB289FE282E

P2860

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

http://www.wikidata.org/entity/Q36887654

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

@en

type

label

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

@en

altLabel

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy

@en

prefLabel

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

@en

P1433

Q36887654-6F4F2B1E-0E57-44AE-B112-A76595E7BAD5

P1476

Q36887654-802CB105-37B5-4DC2-8568-AA992D1AAE93

P2093

Q36887654-00FB3E36-C666-4C8F-9C36-F26CF903D957

Q36887654-138F9965-756F-4BF2-B1AE-617FEC7F1975

Q36887654-1C1E7D60-8D97-4A37-9227-2DB1030259F7

Q36887654-2CBA621D-F96E-4135-99C9-C0A038D7C39A

Q36887654-4A57FB02-C692-4EF0-9D41-CB1B17CEC14E

Q36887654-4CA7391E-D8C6-4A17-85A1-EF3CA10DEAFA

Q36887654-6C311659-CDCC-436A-AA14-9613E1F7D1D5

Q36887654-73CB08A6-A854-4C66-841F-8F7A2922B6F8

Q36887654-8BB129A4-333E-43E5-BAEB-4291C6692881

Q36887654-9CFFE4AF-019F-46EA-90C7-47938F527153

P2860

Q36887654-2356E6D5-914B-407B-BF95-0633D56BEAE4

Q36887654-2D21A699-2E7F-45AE-908A-9943C23ECA8E

Q36887654-30A45FA7-BA96-4060-941A-E611DE616892

Q36887654-3203BA55-3F57-496D-AB4F-52FAD817B5E4

Q36887654-363FC404-3F9E-4656-865F-D354EF927AAE

Q36887654-515462D8-4374-425F-95CA-182413EFD027

Q36887654-78B9495E-BDCC-49F9-957A-28EA867E827C

Q36887654-8EA18B34-B5E4-47BF-8974-D3C205345D79

Q36887654-A94DC059-0660-4869-A972-E6C9A9C0B859

Q36887654-A9704426-F73E-42A7-8E4F-7861969187F6

P304

Q36887654-2F178C60-EC50-423D-91B0-3F33CACE61A3

P31

Q36887654-B95EE965-BDD3-40F6-B7B7-E4BDBE64E4A5

P356

Q36887654-6EFEB903-1144-4F3D-8F32-13594E216AB6

P407

Q36887654-39513853-EDAC-4351-B634-01170A093F14

P433

Q36887654-27716E36-4874-4573-A83D-18A851400E52

P478

Q36887654-1C2B3343-5B5D-42EE-B3D2-BB02FA421E3F

P50

Q36887654-0885B436-3594-4B1B-B07C-1F087F09B14D

Q36887654-49AF769B-F85E-4D36-8DE5-48EFADCE76D9

Q36887654-5B09076B-E01E-45B5-BDCB-F743E83DCED8

Q36887654-901375BD-4D79-4B65-A84E-27D15C876236

P577

Q36887654-C92693C5-27B7-42D2-B8DD-1990F775924C

P5875

Q36887654-2BFC2E7D-8568-453F-A067-52E32E23D8A2

P698

Q36887654-2CF0D7F4-3B7F-4CD1-BA37-D0D414E15AEB

P921

Q36887654-118C13FD-0692-49BC-A676-9E88586EA29E

P932

Q36887654-83B5E3C6-DB43-40A3-BC8A-325C521D1F33

P356

P1433

Journal of the National Cancer Institute

P1476

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy

@en

P2093

Amaro Taylor-Weiner

http://www.w3.org/2001/XMLSchema#string

David J Panka

http://www.w3.org/2001/XMLSchema#string

David N Louis

http://www.w3.org/2001/XMLSchema#string

Dennie T Frederick

http://www.w3.org/2001/XMLSchema#string

Fred G Barker

http://www.w3.org/2001/XMLSchema#string

Gad Getz

http://www.w3.org/2001/XMLSchema#string

Ganesh M Shankar

http://www.w3.org/2001/XMLSchema#string

Ian F Dunn

http://www.w3.org/2001/XMLSchema#string

Javier M Romero

http://www.w3.org/2001/XMLSchema#string

Malak Abedalthagafi

http://www.w3.org/2001/XMLSchema#string

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Absolute quantification of somatic DNA alterations in human cancer

Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma

Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.

The superiority of conservative resection and adjuvant radiation for craniopharyngiomas

Assaying for BRAF V600E in tissue and blood in melanoma.

P304

djv310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJV310

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Daniel P Cahill

Priscilla K Brastianos

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283121561

http://www.w3.org/2001/XMLSchema#string

P698

26498373

http://www.w3.org/2001/XMLSchema#string

P921

craniopharyngioma

P932

4862417

http://www.w3.org/2001/XMLSchema#string